Found 52 matching trials
Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus
PHASE3This is a multicenter, randomized, double-blind, parallel, Vildagliptin and...
Location
The Second People's Hospital of Hefei
Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy
PHASE2The purpose of this study is to compare the effect of a single administrati...
Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes
PHASE3The purpose of this study is to evaluate the effect of Dipeptidyl peptidase...
Location
Azienda Opedaliera-Universitaria
Comparison of Once-Weekly Trelagliptin vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes
NAThis randomized controlled trial evaluated the efficacy of once-weekly trel...
Status
Active Not Recruiting
Location
PNS Hafeez - Naval Hospital
Phase 4 Study in the Elderly Patients With T2DM
PHASE4The study will assess the incidence of Hypoglycemia: Percent of patients pr...
Location
Novartis Investigative Site
Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA)
N/AGIOIA represents a multicenter pragmatic prospective cohort study, aimed at...
Functional Improvement of Progenitor Cells and Endothelial Function by Vildagliptin in Diabetes Mellitus (FINNjA-DM).
PHASE2SDF-1, an important cytokine for neovascularisation is cleaved by (dipeptid...
Location
Department of Cardiology
Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus
PHASE2Diabetes mellitus (DM) is a complex metabolic disorder characterized by hyp...
Location
Faculty of medicine, Tanta University
Bioequivalence Study to Compare Metformin / Vildagliptin Versus Galvumet®
PHASE1The aim of this study is to assess bioequivalence between a single oral dos...
Location
Centre National Chalbi Belkahia de Pharmacovogilance
Incretin-based Drugs and the Risk of Heart Failure
N/AThe purpose of this study is to determine whether incretin-based drugs (use...
Location
Lady Davis Institute for Medical Research, Jewish General Hospital